This may explain why women who had received local treatment more recently had been also at better risk for developing cervical or vaginal cancers, they recommend. Licensed from medwireNews with authorization from Springer Health care Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.. Call for long follow-up after CIN3 treatment By Kirsty Oswald, medwireNews Reporter Researchers from Sweden say that women who have been treated for cervical precancer should receive lifelong follow-up, after finding that their risk for dying from vaginal or cervical cancers markedly increases after the age group of 60 years. And the study findings, released in the BMJ, also show that ladies of all ages previously treated for cervical intraepithelial neoplasia grade 3 have a considerably increased risk for loss of life from invasive vaginal or cervical tumor weighed against women in the general population.For make use of against late-stage melanomaDiscovery may open new doors to focusing on how melanoma grows and spreadsUCSF-led experts map out melanoma's genetic trajectoriesThe organization reported revenue of $45.4 million for the six-month period ended December 31, 2011, compared to revenue of $35.0 million for the same period in fiscal 2011. December 31 Net reduction for the six months ended, 2011, was $7.4 million, or per talk about, compared to a net loss of $23.1 million, or per share, reported in the same six-month period in fiscal 2011. ‘Array expects to have multiple readouts on data in calendar 2012 and we anticipate sharing results over summer and winter,’ said Kyle Lefkoff, Executive Chairman, Array BioPharma.